Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Association Between Insulin Resistance and Beta Cell Function With HbA1C in Diabetics
This completed clinical trial examined the relationship between insulin resistance, beta cell function, and HbA1C levels in individuals with…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor [Phase 4]
This Phase 4 clinical trial comparing a DPP-4 inhibitor with an SGLT-2 inhibitor in people with Type 2 diabetes mellitus and ischemic heart …
-
CLINICAL_TRIALS research · 2018-07-19Clinical Trial Update: T-regulatory Cells in Diabetic Type Two Nephropathy
This entry reports an ongoing clinical trial investigating regulatory T cells as a treatment for diabetic nephropathy in type 2 diabetes, wi…
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: Concurrent Training in Type 2 Diabetes [NA]
A sponsor update indicates that the University of Birmingham trial evaluating concurrent training for Type 2 Diabetes Mellitus has been term…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity
ClinicalTrials.gov study update on a completed trial examining how race-related adiposity influences mechanisms that determine insulin sensi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: SGLT2 Inhibition in Diabetes and Heart Failure
The trial update indicates completion of a study evaluating SGLT2 inhibitors in patients with type 2 diabetes mellitus and systolic heart fa…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Evaluation of the Effect of Pulsatile Cuts Stendo3 on Vascular Function Patients With Diabetes Type 2 [NA]
A completed clinical trial evaluating the effect of Pulsatile Cuts Stendo3 on vascular function in patients with Type 2 diabetes mellitus.
-
FDA approval · 2018-07-16FDA Approved: GLIPIZIDE — Original Application (Northstar Rx LLC.)
The FDA approved an original abbreviated new drug application (ANDA) for generic glipizide, manufactured by Northstar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 study evaluating single and multiple doses of oral insulin versus placebo in adults with Type 2 Diabetes Mellitus; results were post…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Effect of NF-кB Dependent Proinflammation on Osteogenic Differentiation of the Mesenchymal Stem Cells in Type 2 Diabetes
This completed study from Chiang Mai University investigates how NF-kB–dependent proinflammation affects osteogenic differentiation of mesen…
-
CLINICAL_TRIALS withdrawal · 2018-07-12Clinical Trial Update: Taking on Diabetes to Advance You (TODAY) [NA]
The clinical trial TODAY (NCT03121508) investigating Type 2 Diabetes Mellitus has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer [Phase 2]
A Phase 2 clinical trial evaluating DIAMEL combined with insulin for diabetic foot ulcers has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes [NA]
A single-arm feasibility study evaluating GlycoLeap, an online lifestyle modification and self-management program for Type 2 Diabetes, has c…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Glucose Kinetics After Wheat and Rye Breads [NA]
Completed clinical trial evaluating glucose kinetics after consumption of wheat and rye breads in individuals with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Healthy Eating and Active Living for Diabetes: Glycemic Index [NA]
A completed clinical trial sponsored by Athabasca University examined glycemic index–focused diet and active living for people with Type 2 d…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy [Phase 3]
Phase 3 trial update evaluating the efficacy of insulin degludec/liraglutide in adults with type 2 diabetes inadequately controlled on GLP-1…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D [NA]
A completed clinical trial from University Hospital Gentofte explores the role of GLP-1 receptor signaling in mediating the glucose-lowering…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes [NA]
A completed clinical trial evaluating the impact of exenatide on cardiovascular exercise performance in individuals with Type 2 diabetes; re…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes [Phase 3]
A Phase 3 study evaluating the combination of saxagliptin and acarbose to improve postprandial glucose in type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia [Phase 3]
Phase 3 clinical trial update evaluating a metformin and rosuvastatin combination in patients with type 2 diabetes mellitus and dyslipidemia…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Linagliptin as Add on to Basal Insulin in the Elderly [Phase 4]
A Phase 4 trial evaluating adding linagliptin to basal insulin in elderly patients with type 2 diabetes has completed and posted results.
-
CLINICAL_TRIALS research · 2018-07-03Clinical Trial Update: Early Changes in Pulmonary Function and Vascular Endothelial Function and the Correlation Between Them in T2DM Patients
This clinical trial update examines early changes in pulmonary function and vascular endothelial function in patients with type 2 diabetes a…
-
FDA approval · 2018-06-29FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for TRULICITY (dulaglutide) from Eli Lilly and Company. The approval updates/expands the drug’s …
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing albiglutide plus insulin glargine to insulin lispro plus insulin glargine in type 2 diabetes; results posted after c…
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: PowerUp for Health: A Diabetes Prevention Program for Men [NA]
This Clinical Trial Update reports the completion of the PowerUp for Health diabetes prevention program for men, with results posted on 2018…